Where does Melchior Material AND Life Science France rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Melchior Material AND Life Science France ranks #29,425 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Melchior Material AND Life Science France hold?

Melchior Material AND Life Science France holds 9 US utility patents granted between 2017 and 2025, spanning 10 technology areas.

What is Melchior Material AND Life Science France's Innovation Score?

Melchior Material AND Life Science France has an Innovation Score of 30.5 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Melchior Material AND Life Science France focus on?

Melchior Material AND Life Science France's top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 4 patents, ranking #1,009 of 2,691 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Melchior Material AND Life Science France's patent grant rate increasing or decreasing?

Melchior Material AND Life Science France's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Melchior Material AND Life Science France's patents?

Melchior Material AND Life Science France's patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Melchior Material AND Life Science France

Q: How is the Melchior Material AND Life Science France patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Melchior ranks #29,425 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 10 technology areas.

#29,425
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.5/100): 13.3
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29425 · Foreign Corporation #29,425 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,425/49,997
PHOTO-FINISH MEG Energy
CPC-FOCUS C07C · 10 areas
INNOV-THIN 30.5/100
CLAIMS-RICH 13.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: MEG Energy Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Melchior’s 30.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (26%) Velocity 3.3 pts (11%) Breadth 11.2 pts (37%) Claim depth 8.0 pts (26%)

Qualcomm Incorporated · highest

85
Melchior Material… · this assignee

30
3D Lighting… · lowest

7

What this shows Melchior's Innovation Score is 30.5/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Melchior?

Each dot is one of Melchior’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Melchior’s own 13.3 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Melchior vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Melchior's grants concentrate

Melchior Material AND Life Science France is a focused PatentsView assignee: 10 CPC subclasses with 44.4% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2017. By volume, Melchior sits between MEG Energy Corp. and Merrimack River Precision Industrial Corporation.

Melchior's three-year grant acceleration

Melchior Material AND Life Science France shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

MEG Energy

9
Mega1

9
Megaforce

9
Mekorot Water

9
Melrok

9
Mems Start

9
Merlyn Mind

9
Merrimack River P…

9
Melchior Material… ◀

9

What this shows Melchior holds 9 patents at rank #29,371, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Melchior

By rank, the assignees closest to #29,371 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Melchior's primary technology class.

Melchior's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Melchior Material AND Life Science France patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	11.1%
2018	1	11.1%
2019	3	33.3%
2021	1	11.1%
2023	1	11.1%
2024	1	11.1%
2025partial year	1	11.1%

Which technologies does Melchior Material AND Life Science France patent most?

C07C - Acyclic OR Carbocyclic Compounds 4

A01M - Catching, Trapping OR Scaring OF Animals ; Apparatus FOR THE Destruction OF Noxious Animals OR Noxious Plants 3

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

F42B - Explosive Charges, e.g. FOR Blasting, Fireworks, Ammunition 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

C07D - Heterocyclic Compounds 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Melchior Material AND Life Science France's patent record in context - here's where to go next.

Melchior Material AND Life Science France's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 44.4% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #29,425 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Melchior Material AND Life Science France against MEG Energy Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.